The online version of this article (doi:10.1007/s13277-016-5354-x) contains supplementary material, which is available to authorized users.
Cadherin switch is specific of epithelial-mesenchymal transition (EMT) and is closely related to tumor cell invasion. However, the molecular mechanism that promotes the phenotypic changes remains unclear and elusive. We found that integrin-linked kinase (ILK) is a key factor involved in cadherin switch. The expression and activity of ILK are elevated in a variety of cancers but its mechanisms are not exactly understood. In this report, we studied the role and mechanism of ILK in EMT of human bladder cancer. We showed that silencing of ILK expression by small interfering RNA (siRNA) significantly abolished the nuclear translocation or the presence of markers associated with EMT like Snail, Twist, Zeb, and beta-catenin. ILK knockdown by siRNA suppressed N-cadherin expression and increased re-expression of E-cadherin in bladder cancer cells. We suggest that ILK is a major signaling factor involved in EMT. It is essential to understand the molecular mechanism of EMT in aim to possibly use it in search for new therapeutic targets.
Gil D, Ciołczyk-Wierzbicka D, Dulińska-Litweka J, Zwawa K, McCubrey JA, Laidler P. The mechanism of contribution of integrin linked kinase (ILK) to epithelial-mesenchymal transition (EMT. Adv Enzym Regul. 2011;51:195–207. CrossRef
McDonalds PC, Fielding AB, Dedhar S. Integrin-linked kinase—essential roles in physiology and cancer biology. J Cell Sci. 2008;121:3121–32. CrossRef
Tran C, Costello P, Sanghera J, et al. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail in APC-/-human colon carcinoma cells. Oncogene. 2001;20:133–40. CrossRef
McPhee TR, McDonald PC, Oloumi A, Dedhar S. Integrin-linked kinase regulates E-cadherin expession through PARP-1. Dev Dynam. 2008;237:2737–47. CrossRef
Gao J, Zhu J, Li H-Y, Pan H-Y, Jiang R, Chen J-X. Small interfering RNA targeting integrin-linked kinase inhibited the growth and induced apoptosis in human bladder cancer cells. Int J Biochem Cell B. 2011;43:1294–304. CrossRef
McCubrey JA, Davis NM, Abrams SL, et al. Diverse roles of GSK-3: tumor promoter-tumor suppressor, target in cancer therapy. Adv Biol Regulation. 2014;54:176–96. CrossRef
Wu C, Dedhar S. Integrin-linked kinase (ILK) and its interactors: a new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes. J Cell Biol. 2008;155:505–10. CrossRef
Luo L, Liu H, Dong Z, Sun L, Peng Y, Liu F. Small interfering RNA targeting ILK inhibits EMT in human peritoneal mesothelial cels through phosphorylation of GSK-3β. Mol Med Rep. 2014;10:137–44. PubMed
Yang Y, Lin H, Zhu Y, Wu H, Zhang J, et al. Integrin-linked kinase inactives the Wnt pathway through connexin. Biochem Pharmacol (Los Angel). 2015. doi: 10.4172/2167-0501.1000192.
Yang Z, Zhang X, Gang H, et al. Up-regulation of gastric cancer cell invasion by Twist is accompanied by N-cadherin and fibronectin expression. BBBRC. 2007;925-930.
Wu K, Fan J, Zhang L, et al. PI3K/Akt to GSK3β-catenin signaling cascade coordinates cell colonization for bladder cancer bone metastasis through regulating ZEB1 transcription. Cell Signal. 2012;4:2273–82. CrossRef
Yang J, Hou Y, Zhou M, Wen S, Zhou J, Xu L, et al. Twist induces epithelial-mesenchymal transition and cell motility in breast cancer via ITGB1-FAK/ILK signaling axis and its associated downstream network. Int J Biochem Cell B. 2016;71:62–71. CrossRef
- Integrin-linked kinase regulates cadherin switch in bladder cancer
- Springer Netherlands
Neu im Fachgebiet Onkologie
Mail Icon II